CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The NOVO project focuses on developing real-time dose verification technology for proton radiotherapy in cancer treatment. This innovation aims to enhance treatment precision and patient outcomes by enabling adaptive therapy based on real-time dose measurements.
The NOVO project will address a fundamental issue in proton radiotherapy (PT) of cancer, namely the lack of real-time dose verification (RDV) that significantly limits the potential of PT due to uncertainties in the precise delivery of the prescribed dose.
In the NOVO project, we will develop the first proof-of-concept of an RDV technology adaptable to any PT treatment and bring the concept to TRL 4 by also considering integration into the PT clinical workflow.
The RDV technology will be pivotal…
HOGSKULEN PA VESTLANDET
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Türkiye, Istanbul
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Norway, Bergen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, WUPPERTAL
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
